Mostrar el registro sencillo del ítem
dc.contributor.author | Fustero, Santos | es_ES |
dc.contributor.author | Cuñat, Ana C. | es_ES |
dc.contributor.author | Flores, Sonia | es_ES |
dc.contributor.author | Baez, Claribel | es_ES |
dc.contributor.author | Oliver, Judit | es_ES |
dc.contributor.author | Cynamon, Michael | es_ES |
dc.contributor.author | Gütschow, Michael | es_ES |
dc.contributor.author | Mertens, Matthias D. | es_ES |
dc.contributor.author | Delgado, Oscar | es_ES |
dc.contributor.author | Tresadem, Gary | es_ES |
dc.contributor.author | Trabanco, Andrés A. | es_ES |
dc.date.accessioned | 2013-11-11T12:48:41Z | |
dc.date.issued | 2011-12-23 | |
dc.identifier.issn | 0947-6539 | |
dc.identifier.uri | http://hdl.handle.net/10251/33420 | |
dc.description.abstract | The preparation of novel fluorinated allylamines and their use as key fragments for the stereoselective synthesis of hydroxyethyl secondary amine (HEA)-type peptidomimetics is described. Our strategy employs chiral sulfinyl imines as synthesis intermediates, by treatment of hemiaminal precursors with two equivalents of vinylmagnesium bromide. The subsequent oxidation of the allylic amines to the corresponding epoxides was achieved by treatment with methyl(trifluoromethyl)dioxirane. Finally, epoxide ring opening with a range of nitrogen nucleophiles provided a library of HEA-derived peptidomimetics with a phenyldifluoromethylene moiety. The biological evaluation of these derivatives revealed compounds with remarkable BACE1 inhibitory activity. Docking studies revealed the influence of the fluorine atoms in the binding mode of the synthesized ligands. Furthermore, the biological evaluation of our final products and synthesis intermediates led to the discovery of compounds with antimicrobial activity against Mycobacterium and Nocardia species. | es_ES |
dc.format.extent | 13 | es_ES |
dc.language | Inglés | es_ES |
dc.publisher | Wiley-VCH Verlag | es_ES |
dc.relation.ispartof | Chemistry - A European Journal | es_ES |
dc.rights | Reserva de todos los derechos | es_ES |
dc.subject | Antimicrobials | es_ES |
dc.subject | BACE1 | es_ES |
dc.subject | Ethanolamines | es_ES |
dc.subject | Fluorine | es_ES |
dc.subject | Peptidomimetics | es_ES |
dc.title | Design, Synthesis, and Biological Evaluation of Novel Fluorinated Ethanolamines | es_ES |
dc.type | Artículo | es_ES |
dc.embargo.lift | 10000-01-01 | |
dc.embargo.terms | forever | es_ES |
dc.identifier.doi | 10.1002/chem.201102078 | |
dc.rights.accessRights | Cerrado | es_ES |
dc.description.bibliographicCitation | Fustero, S.; Cuñat, AC.; Flores, S.; Baez, C.; Oliver, J.; Cynamon, M.; Gütschow, M.... (2011). Design, Synthesis, and Biological Evaluation of Novel Fluorinated Ethanolamines. Chemistry - A European Journal. 17:14772-14784. doi:10.1002/chem.201102078 | es_ES |
dc.description.accrualMethod | S | es_ES |
dc.relation.publisherversion | http://dx.doi.org/10.1002/chem.201102078 | es_ES |
dc.description.upvformatpinicio | 14772 | es_ES |
dc.description.upvformatpfin | 14784 | es_ES |
dc.type.version | info:eu-repo/semantics/publishedVersion | es_ES |
dc.description.volume | 17 | es_ES |
dc.relation.senia | 241513 | |
dc.description.references | Brookmeyer, R., Johnson, E., Ziegler-Graham, K., & Arrighi, H. M. (2007). Forecasting the global burden of Alzheimer’s disease. Alzheimer’s & Dementia, 3(3), 186-191. doi:10.1016/j.jalz.2007.04.381 | es_ES |
dc.description.references | Jakob-Roetne, R., & Jacobsen, H. (2009). Die Alzheimer-Demenz: von der Pathologie zu therapeutischen Ansätzen. Angewandte Chemie, 121(17), 3074-3105. doi:10.1002/ange.200802808 | es_ES |
dc.description.references | Jakob-Roetne, R., & Jacobsen, H. (2009). Alzheimer’s Disease: From Pathology to Therapeutic Approaches. Angewandte Chemie International Edition, 48(17), 3030-3059. doi:10.1002/anie.200802808 | es_ES |
dc.description.references | Jellinger, K. A. (2006). Alzheimer 100 – highlights in the history of Alzheimer research. Journal of Neural Transmission, 113(11), 1603-1623. doi:10.1007/s00702-006-0578-3 | es_ES |
dc.description.references | Hardy, J., & Higgins, G. (1992). Alzheimer’s disease: the amyloid cascade hypothesis. Science, 256(5054), 184-185. doi:10.1126/science.1566067 | es_ES |
dc.description.references | Selkoe, D. J. (1991). The molecular pathology of Alzheimer’s disease. Neuron, 6(4), 487-498. doi:10.1016/0896-6273(91)90052-2 | es_ES |
dc.description.references | Hardy, J. (2002). The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics. Science, 297(5580), 353-356. doi:10.1126/science.1072994 | es_ES |
dc.description.references | Crouch, P. J., Harding, S.-M. E., White, A. R., Camakaris, J., Bush, A. I., & Masters, C. L. (2008). Mechanisms of Aβ mediated neurodegeneration in Alzheimer’s disease. The International Journal of Biochemistry & Cell Biology, 40(2), 181-198. doi:10.1016/j.biocel.2007.07.013 | es_ES |
dc.description.references | Dillen, K., & Annaert, W. (2006). A Two Decade Contribution of Molecular Cell Biology to the Centennial of Alzheimer’s Disease: Are We Progressing Toward Therapy? International Review of Cytology, 215-300. doi:10.1016/s0074-7696(06)54005-7 | es_ES |
dc.description.references | Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., … John, V. (1999). Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature, 402(6761), 537-540. doi:10.1038/990114 | es_ES |
dc.description.references | Vassar, R. (1999). Beta-Secretase Cleavage of Alzheimer’s Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE. Science, 286(5440), 735-741. doi:10.1126/science.286.5440.735 | es_ES |
dc.description.references | Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., … Gurney, M. E. (1999). Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase activity. Nature, 402(6761), 533-537. doi:10.1038/990107 | es_ES |
dc.description.references | Lin, X., Koelsch, G., Wu, S., Downs, D., Dashti, A., & Tang, J. (2000). Human aspartic protease memapsin 2 cleaves the beta -secretase site of beta -amyloid precursor protein. Proceedings of the National Academy of Sciences, 97(4), 1456-1460. doi:10.1073/pnas.97.4.1456 | es_ES |
dc.description.references | Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., Chapman, C., … Christie, G. (1999). Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase. Molecular and Cellular Neuroscience, 14(6), 419-427. doi:10.1006/mcne.1999.0811 | es_ES |
dc.description.references | Cole, S. L., & Vassar, R. (2007). The Alzheimer’s disease Beta-secretase enzyme, BACE1. Molecular Neurodegeneration, 2(1), 22. doi:10.1186/1750-1326-2-22 | es_ES |
dc.description.references | Maillard, M. C., Hom, R. K., Benson, T. E., Moon, J. B., Mamo, S., Bienkowski, M., … John, V. (2007). Design, Synthesis, and Crystal Structure of Hydroxyethyl Secondary Amine-Based Peptidomimetic Inhibitors of Human β-Secretase†. Journal of Medicinal Chemistry, 50(4), 776-781. doi:10.1021/jm061242y | es_ES |
dc.description.references | Purser, S., Moore, P. R., Swallow, S., & Gouverneur, V. (2008). Fluorine in medicinal chemistry. Chem. Soc. Rev., 37(2), 320-330. doi:10.1039/b610213c | es_ES |
dc.description.references | Muller, K., Faeh, C., & Diederich, F. (2007). Fluorine in Pharmaceuticals: Looking Beyond Intuition. Science, 317(5846), 1881-1886. doi:10.1126/science.1131943 | es_ES |
dc.description.references | Hagmann, W. K. (2008). The Many Roles for Fluorine in Medicinal Chemistry. Journal of Medicinal Chemistry, 51(15), 4359-4369. doi:10.1021/jm800219f | es_ES |
dc.description.references | Tripathi, R. P., Tewari, N., Dwivedi, N., & Tiwari, V. K. (2005). Fighting tuberculosis: An old disease with new challenges. Medicinal Research Reviews, 25(1), 93-131. doi:10.1002/med.20017 | es_ES |
dc.description.references | Khetan, S. K., & Collins, T. J. (2007). Human Pharmaceuticals in the Aquatic Environment: A Challenge to Green Chemistry. Chemical Reviews, 107(6), 2319-2364. doi:10.1021/cr020441w | es_ES |
dc.description.references | Mlostoń, G., Obijalska, E., & Heimgartner, H. (2010). Synthesis of β-amino-α-trifluoromethyl alcohols and their applications in organic synthesis. Journal of Fluorine Chemistry, 131(8), 829-843. doi:10.1016/j.jfluchem.2010.05.014 | es_ES |
dc.description.references | Smits, R., Cadicamo, C. D., Burger, K., & Koksch, B. (2008). Synthetic strategies to α-trifluoromethyl and α-difluoromethyl substituted α-amino acids. Chemical Society Reviews, 37(8), 1727. doi:10.1039/b800310f | es_ES |
dc.description.references | Fustero, S., Sanz-Cervera, J., Aceña, J., & Sánchez-Roselló, M. (2009). Nitrogen-Containing Organofluorine Derivatives: An Overview. Synlett, 2009(04), 525-549. doi:10.1055/s-0028-1087806 | es_ES |
dc.description.references | Sorochinsky, A. E., & Soloshonok, V. A. (2010). Asymmetric synthesis of fluorine-containing amines, amino alcohols, α- and β-amino acids mediated by chiral sulfinyl group. Journal of Fluorine Chemistry, 131(2), 127-139. doi:10.1016/j.jfluchem.2009.09.015 | es_ES |
dc.description.references | Sani, M., Volonterio, A., & Zanda, M. (2007). The Trifluoroethylamine Function as Peptide Bond Replacement. ChemMedChem, 2(12), 1693-1700. doi:10.1002/cmdc.200700156 | es_ES |
dc.description.references | Pesenti, C., Arnone, A., Bellosta, S., Bravo, P., Canavesi, M., Corradi, E., … Zanda, M. (2001). Total synthesis of a pepstatin analog incorporating two trifluoromethyl hydroxymethylene isosteres (Tfm-GABOB) and evaluation of Tfm-GABOB containing peptides as inhibitors of HIV-1 protease and MMP-9. Tetrahedron, 57(30), 6511-6522. doi:10.1016/s0040-4020(01)00543-9 | es_ES |
dc.description.references | Fustero, S., Flores, S., Cuñat, A. C., Jiménez, D., del Pozo, C., Bueno, J., & Sanz-Cervera, J. F. (2007). Synthesis of fluorinated allylic amines: Reaction of 2-(trimethylsilyl)ethyl sulfones and sulfoxides with fluorinated imines. Journal of Fluorine Chemistry, 128(10), 1248-1254. doi:10.1016/j.jfluchem.2007.05.006 | es_ES |
dc.description.references | Kuduk, S. D., Marco, C. N. D., Pitzenberger, S. M., & Tsou, N. (2006). Asymmetric addition reactions of Grignard reagents to chiral 2-trifluoromethyl tert-butyl (Ellman) sulfinimine–ethanol adducts. Tetrahedron Letters, 47(14), 2377-2381. doi:10.1016/j.tetlet.2006.01.154 | es_ES |
dc.description.references | Liu, G., Cogan, D. A., Owens, T. D., Tang, T. P., & Ellman, J. A. (1999). Synthesis of Enantiomerically PureN-tert-Butanesulfinyl Imines (tert-Butanesulfinimines) by the Direct Condensation oftert-Butanesulfinamide with Aldehydes and Ketones. The Journal of Organic Chemistry, 64(4), 1278-1284. doi:10.1021/jo982059i | es_ES |
dc.description.references | Truong, V. L., Ménard, M. S., & Dion, I. (2007). Asymmetric Syntheses of 1-Aryl-2,2,2-trifluoroethylamines via Diastereoselective 1,2-Addition of Arylmetals to 2-Methyl-N-(2,2,2-trifluoroethylidene)propane-2-sulfinamide. Organic Letters, 9(4), 683-685. doi:10.1021/ol063001q | es_ES |
dc.description.references | Zhao, Q.-Y., Yuan, Z.-L., & Shi, M. (2011). Highly Diastereo- and Enantioselective Vinylogous Mannich Reactions of Fluorinated Aldimines with Siloxyfurans. Advanced Synthesis & Catalysis, 353(4), 637-643. doi:10.1002/adsc.201000843 | es_ES |
dc.description.references | Peltier, H. M., McMahon, J. P., Patterson, A. W., & Ellman, J. A. (2006). The Total Synthesis of Tubulysin D. Journal of the American Chemical Society, 128(50), 16018-16019. doi:10.1021/ja067177z | es_ES |
dc.description.references | Fawcett, J., Griffith, G. A., Percy, J. M., & Uneyama, E. (2004). Unexpectedly Selective Formation and Reactions of Epoxycyclooctenones under Microwave-Mediated Conditions. Organic Letters, 6(8), 1277-1280. doi:10.1021/ol0496327 | es_ES |
dc.description.references | Philippe, C., Milcent, T., Nguyen Thi Ngoc, T., Crousse, B., & Bonnet-Delpon, D. (2009). Synthesis of New Trifluoromethylated Hydroxyethylamine-Based Scaffolds. European Journal of Organic Chemistry, 2009(30), 5215-5223. doi:10.1002/ejoc.200900578 | es_ES |
dc.description.references | Philippe, C., Milcent, T., Crousse, B., & Bonnet-Delpon, D. (2009). Non Lewis acid catalysed epoxide ring opening with amino acid esters. Organic & Biomolecular Chemistry, 7(10), 2026. doi:10.1039/b902081k | es_ES |
dc.description.references | syn R S S R | es_ES |
dc.description.references | Onizawa, Y., Kusama, H., & Iwasawa, N. (2008). Efficient Control of π-Alkyne and Vinylidene Complex Pathways for the W(CO)5(L)-Catalyzed Synthesis of Two Types of Nitrogen-Containing Bicyclic Compounds. Journal of the American Chemical Society, 130(3), 802-803. doi:10.1021/ja0782605 | es_ES |
dc.description.references | Raddatz, P., Jonczyk, A., Minck, K. O., Schmitges, C. J., & Sombroek, J. (1991). Substrate analog renin inhibitors containing replacements of histidine in P2 or isosteres of the amide bond between P3 and P2 sites. Journal of Medicinal Chemistry, 34(11), 3267-3280. doi:10.1021/jm00115a016 | es_ES |
dc.description.references | Gorfe, A. A., & Caflisch, A. (2005). Functional Plasticity in the Substrate Binding Site of β-Secretase. Structure, 13(10), 1487-1498. doi:10.1016/j.str.2005.06.015 | es_ES |
dc.description.references | McGaughey, G. B., Colussi, D., Graham, S. L., Lai, M.-T., Munshi, S. K., Nantermet, P. G., … Holloway, M. K. (2007). β-Secretase (BACE-1) inhibitors: Accounting for 10s loop flexibility using rigid active sites. Bioorganic & Medicinal Chemistry Letters, 17(4), 1117-1121. doi:10.1016/j.bmcl.2006.11.003 | es_ES |
dc.description.references | Craig, I. R., Essex, J. W., & Spiegel, K. (2010). Ensemble Docking into Multiple Crystallographically Derived Protein Structures: An Evaluation Based on the Statistical Analysis of Enrichments. Journal of Chemical Information and Modeling, 50(4), 511-524. doi:10.1021/ci900407c | es_ES |
dc.description.references | Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W., & Taylor, R. D. (2003). Improved protein-ligand docking using GOLD. Proteins: Structure, Function, and Bioinformatics, 52(4), 609-623. doi:10.1002/prot.10465 | es_ES |
dc.description.references | Chen, P. (2006). Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro. Journal of Antimicrobial Chemotherapy, 58(2), 332-337. doi:10.1093/jac/dkl227 | es_ES |
dc.description.references | Nikonenko, B. V., Protopopova, M., Samala, R., Einck, L., & Nacy, C. A. (2007). Drug Therapy of Experimental Tuberculosis (TB): Improved Outcome by Combining SQ109, a New Diamine Antibiotic, with Existing TB Drugs. Antimicrobial Agents and Chemotherapy, 51(4), 1563-1565. doi:10.1128/aac.01326-06 | es_ES |
dc.description.references | R R 14 b 15 50 | es_ES |